Certified by Founder
Lodge
Brixton Biosciences
start up
United States
- Cambridge, MA
- 15/05/2024
- Series B
- $33,000,000
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.
- Industry Biotechnology Research
- Website https://www.brixtonbio.com/
- LinkedIn https://www.linkedin.com/company/brixtonbiosciences/
Lula Commerce | $8,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)
CoreStory | $32,000,000 | (Oct 29, 2025)
Cylerity | $4,000,000 | (Oct 29, 2025)
Sweatpals | $12,000,000 | (Oct 29, 2025)
Polygraf AI | $9,000,000 | (Oct 29, 2025)
EPIC(US) | $10,000,000 | (Oct 29, 2025)
iPNOTE - Your Virtual IP Paralegal | $1,000,000 | (Oct 29, 2025)
Wild Moose | $7,000,000 | (Oct 29, 2025)
UPTIQ | $12,000,000 | (Oct 29, 2025)
Spacial | $10,000,000 | (Oct 29, 2025)
Syllo | $30,000,000 | (Oct 29, 2025)